Country for PR: Hong Kong
Contributor: AAP Medianet International
Tuesday, July 17 2018 - 13:23
AsiaNet
Monash-CUHK PhD Collaboration Well Placed for Hong Kong's Biotech Boom
HONG KONG, July 17, 2018 /Medianet International-AsiaNet/--

Recent massive investment in Hong Kong's biotech industry as well as changes to 
the HK’s stock exchange rules allowing the listing of yet to profit biotechs, 
means that Monash University's recent announcement of a PhD exchange program 
with the Chinese University of Hong Kong places the program at the centre of 
potential pipelines for this booming sector.

The Hong Kong government's actions underscore their plans to create a research 
cluster for healthcare technologies that is designed to attract world-class 
scientific research teams to Hong Kong and to collaborate with local research 
teams.   

From Sunday (15 July) Monash-CUHK delegates will gather in Hong Kong to host a 
scientific symposium showcasing projects being co-sponsored by the two 
universities, mainly in the area of stem cell research.

According to Silvio Tiziani, Director, External Strategy and Planning, at 
Monash University's Australian Regenerative Medicine Institute, the joint 
program "places the Australian Regenerative Medicine Institute and Monash 
University at the centre of what will be a booming time for investment in 
biotech in Hong Kong," he said.

"Our PhD students will be developing pipeline discoveries in an environment (in 
Hong Kong) that will be ripe for investment and commercialisation." 

Professor Nellie Georgiou-Karistianis, Associate Dean, Graduate Research at the 
Monash Faculty of Medicine, Nursing and Health Sciences, added that the program 
"aims to provide our PhD students with opportunities to access research 
expertise, resources and infrastructure at both institutions," she said.

"We are the forefront of training the next generation of PhD students providing 
unprecedented opportunities for them to make an impact, in society and in the 
economy."

The PhD exchange programme currently focusses on two common strategic research 
themes for medicine at both Monash and CUHK:

* 'Regenerative Medicine' through Monash's Australian Regenerative Medicine 
Institute and CUHK Institute for Tissue Engineering and Regenerative Medicine.
* 'Biomedical Engineering' through the Monash Institute of Medical Engineering 
and CUHK Chow Yuk Ho Technology Centre for Innovative Medicine.

Examples of PhD projects include:
* Engineering of a hydrogel system to recruit cells at sites of tissue injury
* Adjustable stiffness of biomaterials for bone tissue engineering
* Intracellular delivery of nanoparticles
* A robotic system for walking assistance
* DNA-silicon based nanostructures for biomedical applications
* Understanding and controlling how T cells modulate cardiac muscle regeneration
* 3D Printing of specialised gelatin hydrogels for tissue engineering 
applications

Funding has been made available for a total of 16 collaborative projects with 
both universities keen to significantly expand this program. Professor Peter 
Currie, Director of ARMI, said "there will be enormous benefits to both the 
Monash and the CUHK students, being immersed in world class research facilities 
in two countries, while experiencing different commercialisation environment," 
he said.

Contact: Monash University, T: +61 3 9903 4840 E: media@monash.edu

SOURCE: Monash University
Translations

Chinese - Traditional
Hong Kong